Horseracing anti-doping and medication control program

15 U.S. Code § 3055. Horseracing anti-doping and medication control program

(a) Program required
(1) In general
Not later than the program effective date, and after notice and an opportunity for public comment in accordance with section 3053 of this title, the Authority shall establish a horseracing anti-doping and medication control program applicable to all covered horses, covered persons, and covered horseraces in accordance with the registration of covered persons under section 3054(d) of this title.
(2) Consideration of other breeds
In developing the horseracing anti-doping and medication control program with respect to a breed of horse that is made subject to this chapter by election of a State racing commission or the breed governing organization for such horse under section 3054(k) [1] of this title, the Authority shall consider the unique characteristics of such breed.
(b) Considerations in development of programIn developing the horseracing anti-doping and medication control program, the Authority shall take into consideration the following:
(1)
Covered horses should compete only when they are free from the influence of medications, other foreign substances, and methods that affect their performance.
(2)
Covered horses that are injured or unsound should not train or participate in covered races, and the use of medications, other foreign substances, and treatment methods that mask or deaden pain in order to allow injured or unsound horses to train or race should be prohibited.
(3)
Rules, standards, procedures, and protocols regulating medication and treatment methods for covered horses and covered races should be uniform and uniformly administered nationally.
(4)
To the extent consistent with this chapter, consideration should be given to international anti-doping and medication control standards of the International Federation of Horseracing Authorities and the Principles of Veterinary Medical Ethics of the American Veterinary Medical Association.
This document is only available to subscribers. Please log in or purchase access.